Therapeutics and COVID-19: Living guideline, 10 November 2023

Overview
The WHO Therapeutics and COVID-19: living guideline contains the most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. It is available in pdf format {to adapt} (via the ‘Download’ button) and via an online platform, and is updated regularly as new evidence emerges.
The latest version (version 14 published 10 November 2023) contains important updates to recommendations.
Guidelines regarding the use of drugs to prevent (rather than treat) COVID-19 are included in a separate document, WHO Living guideline: Drugs to prevent COVID-19, that can be accessed via an online platform and in pdf format (or click ‘PDF’ in top right corner of online platform).
Guidelines regarding the clinical management of COVID-19 patients are included in a further document, COVID-19 Clinical management: Living guideline, that can be accessed via an online platform and in pdf format (or click ‘PDF’ in top right corner of online platform).
To view previous (now outdated) versions of this guideline, please see the links below:
Version | Date | Link |
1 | 2 September 2020 | accessible as pdf only |
2 | 20 November 2020 | access as pdf or via online platform |
3 | 17 December 2020 | access as pdf or via online platform) |
4 | 31 March 2021 | access as pdf or via online platform) |
5 | 6 July 2021 | access as pdf or via online platform) |
6 | 24 September 2021 | access as pdf or via online platform |
7 | 7 December 2021 | access as pdf or via online platform |
8 | 14 January 2022 | access as pdf or via online platform |
9 | 3 March 2022 | access as pdf or via online platform |
10 | 22 April 2022 | access as pdf or via online platform |
11 | 14 July 2022 | access as pdf or via online platform |
12 | 16 September 2022 | access as pdf or via online platform |
13 | 13 January 2023 | access as pdf or via online platform |
Read all languages: Chinese I Russian I French I Spanish I Arabic